Reduction in the nephrotoxicity of amphotericin B when administered in 20% intralipid
{{output}}
The administration of amphotericin B (AmB) is often limited by the development of nephrotoxicity. In a pilot crossover trial, aqueous AmB followed by a new preparation of a mixture of AmB with 20% intralipid (AmB-IL) was administered to 10 immunocompromised pa... ...
